The analyst team you couldn't afford to hire. Built to your criteria.
Here's what that looks like in practice.
Prospects and partners you'd never find manually.
A life-sciences consultancy had an extensive criteria for the companies they target, but no way to run those criterias in an automated process. They were finding likely candidates manually, often taking days, then checking whether each one fit.
With RxClarity, we studied their criteria and split match signals into "strong" and "soft" signals. We screened hundreds of companies down to 10 strong prospect matches and several on a watch list, each tagged with the exact signal that triggered it, and surfacing companies their manual search had missed.
"RxClarity is significantly faster than our current process, and found companies we never would have identified."
BD teams, corporate development, CI functions, and consultancies running prospect and target screens.
Keep a live competitive comparison your team actually decides on.
A clinical-stage biotech needed to track trials in specific disease area and defined the output needed from drug tested, biomarker strategy to outcomes, with the exact outputs defined.
RxClarity built the agent whose task is purely to execute this job and to keep this report refreshed as the data continues to change and grow.
"Highly relevant for a company like ours; it could be a day-to-day go-to tool."
Clinical strategy, medical affairs and competitive intelligence teams maintaining an asset or indication landscape.
Catch what's quietly at risk before the readout.
Slipping completion dates, upcoming patent cliffs, competition readout or M&A: the signals that a program or asset is in trouble before it's announced. RxClarity watches for you continuously across all therapy areas and flags each risk with the reason and a next step.
Strategy and portfolio teams tracking their own risk and competitors' openings.